Ultrasound-Guided Glenohumeral Steroid Injection
Comparison Between Anterior and Posterior Approaches for Ultrasound-guided Glenohumeral Steroid Injection: A Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
The investigators compared the results of the ultrasound-guided anterior and posterior approaches to administer glenohumeral steroid injections to patients with primary adhesive capsulitis of the shoulder joint by a single experienced provider.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 29, 2015
CompletedFirst Posted
Study publicly available on registry
June 3, 2015
CompletedSeptember 22, 2023
September 1, 2023
11 months
May 29, 2015
September 20, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
visual analog scale (VAS) for pain
0-10, 0: no pain, 10: very severe pain
initial, Week 3, 7, 13
range of motion (ROM)
degree
initial, Week 3, 7, 13
patient's satisfaction (SAT)
0-10, 0: not satisfied, 10: very much satisfied
initial, Week 3, 7, 13
American Shoulder and Elbow Surgeons (ASES) shoulder score
0-100
initial, Week 3, 7, 13
Constant score
0-100
initial, Week 3, 7, 13
Secondary Outcomes (1)
Accuracy of injection using post-injection X-ray
within 15 minutes after injection
Study Arms (2)
anterior approach
EXPERIMENTALUltrasound-guided anterior approach of glenohumeral joint injection for primary adhesive capsulitis of shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
posterior approach
ACTIVE COMPARATORUltrasound-guided anterior approach of glenohumeral joint injection for primary adhesive capsulitis of shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
Interventions
Glenohumeral steroid injection is performed under ultrasound-guidance by anterior approach. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
Glenohumeral steroid injection is performed under ultrasound-guidance by posterior approach. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
Eligibility Criteria
You may qualify if:
- shoulder pain and limitations of active and passive motion in at least two directions (abduction and forward flexion \< 100, external rotation \< 30, or internal rotation \< L3) on the pre-injection check-up
- those who underwent MRI or ultrasonography with no secondary cause for adhesive capsulitis, such as a rotator cuff tear, calcific tendinitis, or osteoarthritis
You may not qualify if:
- history of fracture or operation on the affected shoulder
- loss to follow-up before 13 weeks after the injection
- receiving another treatment that was different from our protocol within 13 weeks after the injection
- no functional scores within 13 weeks after the injection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, 700-204, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jung-Taek Hwang, MD, PhD
Chuncheon Sacred Heart Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 29, 2015
First Posted
June 3, 2015
Study Start
December 1, 2012
Primary Completion
November 1, 2013
Study Completion
February 1, 2014
Last Updated
September 22, 2023
Record last verified: 2023-09